Vol. 61 No. 6 (2022): Acta Oncologica

Articles

• International assessment of interobserver reproducibility of flap delineation in head and neck carcinoma

  Arnaud Beddok, Leslie Guzene, Alexandre Coutte, David Thomson, Sue S. Yom, Valentin Calugaru, Eivind Blais, Olivier Gilliot, Séverine Racadot, Yoann Pointreau, June Corry, Kenneth Jensen, Sandro Porceddu, Nazim Khalladi, Vianney Bastit, Audrey Lasne-Cardon, Pierre-Yves Marcy, Florent Carsuzaa, Christophe Nioche, Jean Bourhis, Julia Salleron, Juliette Thariat

  672-679

  Published: 2022-06-03

  • PDF

• Comparing Iridium-192 with Cobalt-60 sources in high-dose-rate brachytherapy boost for localized prostate cancer

  Jörg Tamihardja, Stefan Weick, Paul Lutyj, Marcus Zimmermann, Klaus Bratengeier, Michael Flentje, Bülent Polat

  714-719

  Published: 2022-06-03

  • PDF

• Factors affecting outcome in resected EGFR-mutated lung cancer

  Inger Johanne Zwicky Eide, Yngvar Nilssen, Marius Lund-Iversen, Odd Terje Brustugun

  749-756

  Published: 2022-06-03

  • PDF

• Complete pathologic response (pCR) following neoadjuvant pembrolizumab monotherapy in treatment-naive locally advanced, mismatch repair protein-deficient (dMMR) colonic cancer: a case report and literature review

  Alfonso Tan-Garcia, Lai Mun Wang, James Chi-Yong Ngu, Lynne Goh

  780-784

  Published: 2022-06-03

  • PDF

• Exploratory analysis of tumor imaging in a Phase 2 trial with cabozantinib in gastrointestinal stromal tumor: lessons learned from study EORTC STBSG 1317 ‘CaboGIST’

  Anastasios Kyriazoglou, Pieter Jespers, Vincent Vandecavaye, Olivier Mir, Bernd Kasper, Zsuzsanna Papai, Jean-Yves Blay, Antoine Italiano, Facundo Zaffaroni, Saskia Litière, Axelle Nzokirantevye, Patrick Schöffski

  663-668

  Published: 2022-06-03

  • PDF

• Radiation-induced prostate swelling during SBRT of the prostate

  Antti Vanhanen, Petri Reinikainen, Mika Kapanen

  698-704

  Published: 2022-06-03

  • PDF
  • Supplemental Material

• The association between body mass index and pathological complete response in neoadjuvant-treated breast cancer patients

  Ida Skarping, Stine Blaabjerg Pedersen, Daniel Förnvik, Sophia Zackrisson, Signe Borgquist

  731-737

  Published: 2022-06-03

  • PDF

• A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non–small cell lung cancer

  Anne Sibille, Frederique Bustin, Luciano Carestia, Gaetan Catala, Christophe Compère, Kristof Cuppens, Benoit Colinet, Stephanie Coulon, Nele De Brucker, Lore Decoster, Lynn Decoster, Ingel Demedts, Sofie Derijcke, Koen Deschepper, Danny Galdermans, Annelies Janssens, Sebahat Ocak, Christel Oyen, Karin Pat, Thierry Pieters, Vincent Pruniau, Veerle Surmont, Saar Vandekeere, Johan Vansteenkiste

  773-776

  Published: 2022-06-03

  • PDF

• Diffusion tensor imaging in glioblastoma patients treated with volumetric modulated arc radiotherapy: a longitudinal study

  Anna Rydelius, Björn Lampinen, Andreas Rundcrantz, Johan Bengzon, Silke Engelholm, Danielle van Westen, Sara Kinhult, Linda Knutsson, Jimmy Lätt, Markus Nilsson, Pia C. Sundgren

  680-687

  Published: 2022-06-03

  • PDF

• Is there a place for definitive radiotherapy in the treatment of unresectable soft-tissue sarcoma? A systematic review

  Benoît Allignet, Marie-Pierre Sunyach, Xavier Geets, Waisse Waissi

  720-729

  Published: 2022-06-03

  • PDF

• Brain metastases in patients with ovarian cancer

  Dror Limon, Eliya Shachar, Ido Wolf, Lyri Adar, Shira Peleg Hasson, Leora Ferro, Tamar Safra

  757-763

  Published: 2022-06-03

  • PDF

• Adenoid cystic carcinoma of the parotid gland: a first case report on 11C-methionine PET/CT detection of histologically confirmed pulmonary metastases

  Silvia Taralli, Antonella Martino, Alessandra Cancellieri, Lucio Calandriello, Filippo Lococo, Carmelo Caldarella

  669-671

  Published: 2022-06-03

  • PDF

• Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease

  Sherif Ramadan, Kimmen Quan, Kara Schnarr, Rosalyn A. Juergens, Sebastien J. Hotte, Som D. Mukherjee, Anil Kapoor, Brandon M. Meyers, Anand Swaminath

  705-713

  Published: 2022-06-03

  • PDF

• Survival rates and safety associated with chemoradiotherapy followed by surgery and chemoradiotherapy alone for patients with T4 esophageal cancer: a systematic review and meta-analysis

  Chia Ching Lee, Yu Yang Soon, Balamurugan Vellayappan, Francis Ho, Jeremy C. S. Tey

  738-748

  Published: 2022-06-03

  • PDF

• A novel report of nivolumab-induced transient and persistent acantholytic dermatosis associated with multiple cutaneous toxicities in a patient with metastatic melanoma

  Yana Kost, Daiva M. Mattis, Bijal Amin, Daniel E. Sammartino, Beth N. McLellan

  777-779

  Published: 2022-06-03

  • PDF

• Phase 1/2 trial evaluating the effectiveness and safety of dose-adapted Hypofractionated pelvic radiotherapy for Advanced Cervical cancers INeligible for ChemoTherapy (HYACINCT)

  Warren Bacorro, Kathleen Baldivia, Mark Dumago, Maureen Bojador, Abigail Milo, Celestine Marie Trinidad, Jocelyn Mariano, Gil Gonzalez, Teresa Sy Ortin

  688-697

  Published: 2022-06-03

  • PDF

• Radiofrequency ablation, radiation therapy, transarterial chemoembolization, and yttrium 90: no differences for local treatment of liver cancer?

  Alessandro Rizzo, Giovanni Brandi

  730

  Published: 2022-06-03

  • PDF

• Reproductive history, as measured by parity, age at first birth and sex of offspring, and cancer-specific survival after a haematological malignancy

  Anna L. V. Johansson, Paul W. Dickman, Sandra Eloranta, Magnus Björkholm

  764-772

  Published: 2022-06-03

  • PDF